Shilpa Medicare

{
  "main_header": {
    "sid": 780523,
    "name": "Shilpa Medicare",
    "stock_name": "Shilpa Medicare",
    "full_name": "Shilpa Medicare Ltd",
    "name_url": "stocks-analysis/shilpa-medicare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "268.10",
    "chg": -4.6,
    "chgp": "-1.69%",
    "dir": -1,
    "prev_price": "272.70",
    "mcapval": "5,509.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530549,
    "symbol": "SHILPAMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE790G01031",
    "curr_date": "Jan 22",
    "curr_time": "",
    "bse_nse_vol": "3.99 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 22, 2026",
    "traded_date_str": "2026 01 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Shilpa Medicare Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-stock-falls-to-52-week-low-amidst-continued-downtrend-3800662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShilpaMedicareL_priceRelatedfactors_3800662.png",
        "date": "2026-01-22 18:01:06",
        "description": "Shilpa Medicare Ltd has recently touched a 52-week low of ₹265.25, marking a significant decline in its stock price amid a sustained downward trajectory. The stock is currently trading just 1.06% above this low, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shilpa Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-strong-sell-3781201",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShilpaMedicareL_mojoScore_3781201.png",
        "date": "2026-01-05 10:15:12",
        "description": "Shilpa Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shilpa Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-is-rated-strong-sell-3768957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShilpaMedicareL_mojoScore_3768957.png",
        "date": "2025-12-25 12:58:29",
        "description": "Shilpa Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Shilpa Medicare Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-downgraded-to-strong-sell-by-marketsmojo-amid-weak-fundamentals-3756143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShilpaMedicare_mojoScore_3756143.png",
        "date": "2025-12-11 10:10:16",
        "description": "Shilpa Medicare’s market evaluation has undergone a revision reflecting a more cautious outlook, influenced by recent shifts in its fundamental and technical indicators. The pharmaceutical company’s performance metrics reveal a complex picture of valuation appeal contrasted by subdued quality and technical signals, set against a backdrop of sustained negative returns over multiple time frames."
      },
      {
        "title": "Why is Shilpa Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shilpa-medicare-fallingrising-3736153",
        "imagepath": "",
        "date": "2025-11-29 00:48:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>On 28 November, Shilpa Medicare’s shares fell by ₹7.10, or 2.03%, closing at ₹342.00. This decline is part of a broader trend, with the stock underperforming the Sensex and its sector over multiple time frames. Over the past week, the stock has dropped 2.51%, while the Sensex gained 0.56%. The one-month performance shows a 5.11% loss for Shilpa Medicare against a 1.27% rise in the Sensex. Year-to-date, the stock has declined 15.87%, contrasting with the Sensex’s 9.68% gain. Over the last year, the stock’s fall is even more pronounced at 23.74%, while the Sensex rose 8.43%. These figures highlight a persistent underperformance relative to the broader market.</p>\n<p>Intraday trading on 28 November saw the stock touch a low of ₹340.20,..."
      },
      {
        "title": "Shilpa Medicare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-downgraded-to-strong-sell-amid-mixed-financial-and-technical-signals-3717103",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ShilpaMedicare_mojoScore_3717103.png",
        "date": "2025-11-20 08:11:15",
        "description": "Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation following recent financial disclosures and technical analysis. While the company’s quarterly results indicate positive trends in profitability and operational efficiency, certain long-term fundamentals and technical indicators suggest a cautious outlook for investors."
      },
      {
        "title": "Why is Shilpa Medicare falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-shilpa-medicare-fallingrising-3716291",
        "imagepath": "",
        "date": "2025-11-19 22:50:19",
        "description": "As of 19-Nov, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 360.00, which reflects a decrease of Rs 5.85 or 1.6%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 9.92% over that period. Today's trading saw the stock hit an intraday low of Rs 351.8, and it is currently trading below all its moving averages. Additionally, investor participation has decreased significantly, with delivery volume dropping by 57.17% compared to the five-day average. Despite positive financial results over the last nine quarters, including a substantial increase in profits, the stock has underperformed with a year-to-date return of -11.44% and a one-year return of -18.17%, indicating a disconnect between its strong earnings growth and stock performance.\n\nIn the broader market context, Shilpa Medicare's performance contrasts ..."
      },
      {
        "title": "How has been the historical performance of Shilpa Medicare?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-shilpa-medicare-3716191",
        "imagepath": "",
        "date": "2025-11-19 22:42:45",
        "description": "Answer:\nThe historical performance of Shilpa Medicare shows a significant increase in net sales, reaching 1,286.41 Cr in March 2025, up from 1,151.60 Cr in March 2024 and 1,050.11 Cr in March 2023. The total operating income mirrored this growth, with a rise to 1,286.41 Cr in March 2025. However, total expenditure also increased to 969.51 Cr in March 2025, compared to 907.11 Cr in March 2024. Operating profit (PBDIT) saw a substantial rise to 340.20 Cr in March 2025 from 252.66 Cr in March 2024, indicating improved operational efficiency. Profit before tax improved to 123.60 Cr in March 2025, up from 59.11 Cr in March 2024, while profit after tax also rose to 79.57 Cr from 36.74 Cr. The earnings per share increased to 4.0 in March 2025, compared to 3.67 in March 2024. \n\nOn the balance sheet side, total assets grew to 3,297.74 Cr in March 2025 from 3,082.98 Cr in March 2024, with total liabilities also incre..."
      },
      {
        "title": "Is Shilpa Medicare technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-shilpa-medicare-technically-bullish-or-bearish-3713925",
        "imagepath": "",
        "date": "2025-11-19 08:16:05",
        "description": "As of 18 November 2025, the technical trend for Shilpa Medicare has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands, and bearish moving averages on the daily timeframe. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but is mildly bearish on the monthly. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market...."
      }
    ],
    "total": 356,
    "sid": "780523",
    "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523"
  },
  "announcements": [
    {
      "caption": "Assignment Of ESG Rating By SES ESG Research Pvt Ltd",
      "datetime": "16-Jan-2026",
      "details": "Assignment of ESG Rating by SES ESG Research Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of SEBI(LODR) Regulations 2015",
      "datetime": "15-Jan-2026",
      "details": "Sale purchase agreement towards sell of Koanna Healthcare Canada Inc. (a wholly owned subsidiary) of Shilpa Medicare Limited",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31 December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25",
          "dt": "2025-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15",
          "dt": "2015-11-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Shilpa Medicare Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend

2026-01-22 18:01:06

Shilpa Medicare Ltd has recently touched a 52-week low of ₹265.25, marking a significant decline in its stock price amid a sustained downward trajectory. The stock is currently trading just 1.06% above this low, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shilpa Medicare Ltd is Rated Strong Sell

2026-01-05 10:15:12

Shilpa Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Shilpa Medicare Ltd is Rated Strong Sell

2025-12-25 12:58:29

Shilpa Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Shilpa Medicare Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-11 10:10:16

Shilpa Medicare’s market evaluation has undergone a revision reflecting a more cautious outlook, influenced by recent shifts in its fundamental and technical indicators. The pharmaceutical company’s performance metrics reveal a complex picture of valuation appeal contrasted by subdued quality and technical signals, set against a backdrop of sustained negative returns over multiple time frames.

Read full news article

Why is Shilpa Medicare falling/rising?

2025-11-29 00:48:53

Recent Price Movement and Market Comparison

On 28 November, Shilpa Medicare’s shares fell by ₹7.10, or 2.03%, closing at ₹342.00. This decline is part of a broader trend, with the stock underperforming the Sensex and its sector over multiple time frames. Over the past week, the stock has dropped 2.51%, while the Sensex gained 0.56%. The one-month performance shows a 5.11% loss for Shilpa Medicare against a 1.27% rise in the Sensex. Year-to-date, the stock has declined 15.87%, contrasting with the Sensex’s 9.68% gain. Over the last year, the stock’s fall is even more pronounced at 23.74%, while the Sensex rose 8.43%. These figures highlight a persistent underperformance relative to the broader market.

Intraday trading on 28 November saw the stock touch a low of ₹340.20,...

Read full news article

Shilpa Medicare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-11-20 08:11:15

Shilpa Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation following recent financial disclosures and technical analysis. While the company’s quarterly results indicate positive trends in profitability and operational efficiency, certain long-term fundamentals and technical indicators suggest a cautious outlook for investors.

Read full news article

Why is Shilpa Medicare falling/rising?

2025-11-19 22:50:19

As of 19-Nov, Shilpa Medicare Ltd is experiencing a decline in its stock price, currently at Rs 360.00, which reflects a decrease of Rs 5.85 or 1.6%. The stock has been underperforming, having fallen consecutively for the last five days, resulting in a total decline of 9.92% over that period. Today's trading saw the stock hit an intraday low of Rs 351.8, and it is currently trading below all its moving averages. Additionally, investor participation has decreased significantly, with delivery volume dropping by 57.17% compared to the five-day average. Despite positive financial results over the last nine quarters, including a substantial increase in profits, the stock has underperformed with a year-to-date return of -11.44% and a one-year return of -18.17%, indicating a disconnect between its strong earnings growth and stock performance. In the broader market context, Shilpa Medicare's performance contrasts ...

Read full news article

How has been the historical performance of Shilpa Medicare?

2025-11-19 22:42:45

Answer: The historical performance of Shilpa Medicare shows a significant increase in net sales, reaching 1,286.41 Cr in March 2025, up from 1,151.60 Cr in March 2024 and 1,050.11 Cr in March 2023. The total operating income mirrored this growth, with a rise to 1,286.41 Cr in March 2025. However, total expenditure also increased to 969.51 Cr in March 2025, compared to 907.11 Cr in March 2024. Operating profit (PBDIT) saw a substantial rise to 340.20 Cr in March 2025 from 252.66 Cr in March 2024, indicating improved operational efficiency. Profit before tax improved to 123.60 Cr in March 2025, up from 59.11 Cr in March 2024, while profit after tax also rose to 79.57 Cr from 36.74 Cr. The earnings per share increased to 4.0 in March 2025, compared to 3.67 in March 2024. On the balance sheet side, total assets grew to 3,297.74 Cr in March 2025 from 3,082.98 Cr in March 2024, with total liabilities also incre...

Read full news article

Is Shilpa Medicare technically bullish or bearish?

2025-11-19 08:16:05

As of 18 November 2025, the technical trend for Shilpa Medicare has changed from mildly bearish to bearish. The current technical stance is bearish with moderate strength. Key indicators driving this stance include a bearish MACD on the weekly chart, bearish Bollinger Bands, and bearish moving averages on the daily timeframe. The KST is also bearish on the weekly chart, while the Dow Theory shows a mildly bullish signal on the weekly but is mildly bearish on the monthly. Overall, the combination of these indicators suggests a prevailing bearish sentiment in the market....

Read full news article

View All News